← SynDRA
CYCLOBENZAPRINE
SynDRA canonical compound SYN0001333 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
| Indication | spasms |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- HTR2A
- HTR2C
- ABCB1
- ADRA2C
- AOX1
- CACNA1B
- CHRM1
- CHRM2
- CHRM3
- HRH1
- HTR2B
- HTR6
Mechanisms of action (all sources)
- Serotonin receptor agonist
- Adrenergic receptor agonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- HTR2C ANTAGONIST
- Serotonin 2c (5-HT2c) receptor antagonist
- ADRA2C ANTAGONIST
Drug classes
- Antidepressive Agents
- Antidepressive Agents, Tricyclic
- Central Nervous System Agents
- Central Nervous System Depressants
- Muscle Relaxants, Central
- Neuromuscular Agents
- Peripheral Nervous System Agents
- Psychotropic Drugs
- Tranquilizing Agents
- Muscle Relaxant
ATC classes
- M03B · MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Cross-references
Synonyms
- proheptatrien
- proheptatriene
- cyclobenzaprine hydrochloride
- cyclobenzaprine HCl
- Ciclobenzaprina
- MK-130 (AS THE BASE)
- TNX-102
- Cyclobenz
- Cyclobenzaprinum
- Fexmid
- Flexeril
- Lisseril
- Proeptatriene
- Proheptatrien
- Proheptatriene
- Yurelax
- Cyclobenzaprine [INN]
- Flexeril hydrochloride
- Proeptatriene [Italian]
- MK 130
- NCI78206
- Amrix (TN)
- Ciclobenzaprina [INN-Spanish]
- Cyclobenzaprine (INN)
- Cyclobenzaprinum [INN-Latin]
- Fexmid(TN)
- Flexeril (TN)
- MK-130 HCl
- Ro 4-1577
- Apo-Cyclobenzaprine (TN)
- N,N-Dimethyl-3-(dibenzo(a,d)cycloheptene-4-ylidene)propylamine
- N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine
- N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine
- 1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-(9CI)
- 10,11-Dehydroamitriptyline
- 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine
- 3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine
- 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine
Reported adverse events
- Chest pain
- Hypersensitivity
- Hypertension
- Purpura
- Seizure
- Syncope
- Tachycardia
- Vomiting
- Ageusia
- Dizziness
- Fatigue
- Headache
Look up CYCLOBENZAPRINE in the interactive SynDRA portal →